Cargando…

Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review

PURPOSE: The newly emerged coronavirus (SARS-CoV-2) continues to infect humans, and no completely efficient treatment has yet been found. Antibody therapy is one way to control infection caused by COVID-19, but the use of classical antibodies has many disadvantages. Heavy chain antibodies (HCAbs) ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aria, Hamid, Mahmoodi, Fatemeh, Ghaheh, Hooria Seyedhosseini, Faranak mavandadnejad, Zare, Hamed, Heiat, Mohammad, Bakherad, Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730734/ https://www.ncbi.nlm.nih.gov/pubmed/34995616 http://dx.doi.org/10.1016/j.ab.2022.114546

Ejemplares similares

Nanobodies, the potent agents to detect and treat the Coronavirus infections: A systematic review
por: Zare, Hamed, et al.
Publicado: (2021)

Nanobodies: a tool to open new horizons in diagnosis and treatment of prostate cancer
por: Hosseindokht, Maryam, et al.
Publicado: (2021)

Nanobodies; new molecular instruments with special specifications for targeting, diagnosis and treatment of triple-negative breast cancer
por: Bakherad, Hamid, et al.
Publicado: (2022)

Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function
por: Bakherad, Hamid, et al.
Publicado: (2020)

Improving the solubility, activity, and stability of reteplase using in silico design of new variants
por: Ghaheh, Hooria Seyedhosseini, et al.
Publicado: (2019)

Reteplase: Structure, Function, and Production
por: Mohammadi, Elmira, et al.
Publicado: (2019)

Investigation of Supercharging as A Strategy to Enhance the Solubility and Plasminogen Cleavage Activity of Reteplase
por: Seyedhosseini Ghaheh, Hooria, et al.
Publicado: (2020)

Investigation of the Association between 5-Hydroxytryptamine Transporter Gene-Linked Polymorphic Region with Type 2 Diabetes Mellitus, Obesity and Biochemical Profiles of Serum in Iranian Population
por: Asadzadeh, Azizeh, et al.
Publicado: (2019)

Nanobiological studies on drug design using molecular mechanic method
por: Ghaheh, Hooria Seyedhosseini, et al.
Publicado: (2015)

Psychological impact of COVID-19 on health-care workers: A multicenter cross-sectional study
por: Mousavi, Mohammad, et al.
Publicado: (2021)

Risk factors of placental abruption
por: Ghaheh, Hooria Seyedhosseini, et al.
Publicado: (2013)

The effects of alpha lipoic acid (ALA) supplementation on blood pressure in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials
por: Vajdi, Mahdi, et al.
Publicado: (2023)

A novel approach to enhance the performance of kallikrein 6 enzyme using Pichia pastoris GS115 as a host
por: Mahmoodi, Fatemeh, et al.
Publicado: (2023)

Targeting and ultrabroad insight into molecular basis of Resistance-nodulation-cell division efflux pumps
por: Seyedhosseini Ghaheh, Hooria, et al.
Publicado: (2022)

Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
por: Yang, Emily Y., et al.
Publicado: (2020)

The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics
por: Naidoo, Dhaneshree Bestinee, et al.
Publicado: (2023)

Nanobodies: A Review of Generation, Diagnostics and Therapeutics
por: Jin, Bo-kyung, et al.
Publicado: (2023)

Nanobodies as Diagnostic and Therapeutic Tools for Cardiovascular Diseases (CVDs)
por: Bocancia-Mateescu, Lorena-Andreea, et al.
Publicado: (2023)

The Therapeutic Potential of Nanobodies
por: Jovčevska, Ivana, et al.
Publicado: (2019)

Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19
por: Nadeali, Zakiye, et al.
Publicado: (2022)

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
por: Bannas, Peter, et al.
Publicado: (2017)

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2
por: Ye, Gang, et al.
Publicado: (2020)

The Therapeutic Outlook in Pediatric Medicine
Publicado: (1906)

Frontier Therapeutics and Vaccine Strategies for SARS-CoV-2 (COVID-19): A Review
por: SHEIKHSHAHROKH, Amirhossein, et al.
Publicado: (2020)

Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19)
por: Bessalah, Salma, et al.
Publicado: (2021)

Fabrication of Calcium Sulfate Coated Selenium Nanoparticles and Corresponding In-Vitro Cytotoxicity Effects Against 4T1 Breast Cancer Cell Line
por: Faghfuri, Elnaz, et al.
Publicado: (2021)

The Therapeutic Outlook in Organic Nervous Diseases
por: Adams, Douglas K.
Publicado: (1936)

Pathological mechanisms and therapeutic outlooks for arthrofibrosis
por: Usher, Kayley M., et al.
Publicado: (2019)

An Outlook on Harnessing Technological Innovative Competence in Sustainably Transforming African Agriculture
por: Asem ‐ Hiablie, Senorpe, et al.
Publicado: (2023)

Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody
por: Ranjibar, Farideh, et al.
Publicado: (2018)

Nanobodies Enhancing Cancer Visualization, Diagnosis and Therapeutics
por: Naidoo, Dhaneshree Bestinee, et al.
Publicado: (2021)

Addition of MitoTEMPO to the maturation medium improves in vitro maturation competence of bovine oocytes
por: Yousefian, Iman, et al.
Publicado: (2022)

Anti-SARS-CoV-1 and −2 nanobody engineering towards avidity-inspired therapeutics
por: Obeng, Eugene M., et al.
Publicado: (2022)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Chen, Xun, et al.
Publicado: (2021)

Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection
por: Esmagambetov, I. B., et al.
Publicado: (2021)

Outlook of various diagnostics and nanodiagnostic techniques for COVID-19
por: Preethi, Mosam, et al.
Publicado: (2022)

Therapeutische Nanobodies gegen SARS-CoV-2
por: Güttler, Thomas, et al.
Publicado: (2022)

SARS-CoV-2 nanobodies 2.0
por: Labroussaa, Fabien, et al.
Publicado: (2021)

CAMEL NANOBODIES NEUTRALIZE SARS-COV-2 VARIANTS
por: Hong, Jessica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6pltb9gmpm29fquttf57rfb6q0